The 2026 DMDG-GMP-SPS Joint Meeting, taking place October 5-7 in Prague, will bring together industry leaders to discuss the latest advancements in pharmacokinetics, ADME, and translational sciences. The multi-day program features dedicated sessions on novel drug modalities, advanced in vitro models, and the growing role of AI and modeling technologies in modern drug discovery.